白质微结构异常与衰老及阿尔茨海默病认知功能
这项多队列预后研究分析4467名50岁以上参与者,发现白质自由水(FW)与各认知域表现及纵向衰退关联最强,尤其记忆;扣带束和穹窿等边缘系统白质FW与记忆表现和衰退关联最强,且FW与基线诊断、灰质萎缩、APOE ε4及淀粉样蛋白阳性交互预测更差认知。
要点
- 白质自由水是衰老和AD相关认知障碍中与认知表现及衰退关联最强的微结构指标。
- 扣带束和穹窿等边缘系统白质自由水与记忆表现和衰退关联最强。
- 白质自由水与基线诊断、灰质萎缩、APOE ε4及淀粉样蛋白阳性交互预测认知衰退。
核心结论
- 白质微结构改变尤其是自由水在衰老和AD相关认知障碍的认知衰退中起关键作用。
- 边缘系统尤其扣带束和穹窿是与认知衰退关联的关键区域。
- 将自由水校正指标与其他AD生物标志物整合可能进一步阐明神经退行性变的生物学机制。
研究设计与样本
- 这项预后研究为多中心队列研究的二次分析,数据来自9个队列,采集于2002年9月至2022年11月。
- 纳入标准包括有弥散加权磁共振成像(dMRI)数据、域特异性认知复合z评分、人口学和临床数据、年龄50岁及以上并通过神经影像质量控制。
- 共纳入4467名参与者,进行9208次纵向认知评估;2698名(60.4%)为女性,平均年龄(SD)74.3(9.2)岁;3213名认知正常,972名轻度认知障碍,282名AD痴呆。
主要发现
- 白质自由水(FW)与所有认知域的横断面认知表现和纵向认知衰退关联最强,尤其记忆。
- 边缘束如扣带束的FW与记忆表现关联最强(扣带束:β = -0.718;P < .001;穹窿:β = -1.069;P < .001),与记忆衰退关联最强(扣带束:β = -0.115;P < .001;穹窿:β = -0.153;P < .001)。
- 白质FW指标与基线诊断、灰质萎缩、APOE ε4状态和淀粉样蛋白阳性交互预测更差认知表现和加速认知衰退。
- 显著交互包括穹窿FW与海马体积(β = 10.598;P < .001)、扣带束FW与SPARE-AD指数(β = -0.532;P < .001)、颞下回经胼胝体束FW与基线诊断(β = -0.537;P < .001),均预测更差记忆表现。
临床怎么用
- 在dMRI研究中应进行自由水校正以准确评估白质微结构。
- 关注边缘系统尤其扣带束和穹窿的白质自由水作为认知衰退的关键影像标志物。
- 整合自由水校正指标与其他AD生物标志物可能有助于阐明神经退行性变的生物学机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: There has yet to be a large-scale study quantifying the association between white matter microstructure and cognitive performance and decline in aging and Alzheimer disease (AD). OBJECTIVE: To investigate the associations between tract-specific white matter microstructure and cognitive performance and decline in aging and AD-related cognitive impairment. DESIGN SETTING AND PARTICIPANTS: This prognostic study of aging and AD, a secondary data analysis of multisite cohort studies, acquired data from 9 cohorts between September 2002 and November 2022. Participants were eligible if they had diffusion-weighted magnetic resonance imaging (dMRI) data, domain-specific cognitive composite z scores, demographic and clinical data, were aged 50 years or older, and passed neuroimaging quality control. Demographic and clinical covariates included age, sex, education, race and ethnicity, APOE haplotype status (ε2, ε3, ε4), and clinical status. The present study was conducted from June 2024 to February 2025. EXPOSURES: White matter microstructure and cognitive performance and decline. MAIN OUTCOMES AND MEASURES: Clinical diagnosis, imaging measures (dMRI, T1-weighted MRI, and amyloid and tau positron emission tomography), and cognitive tests. RESULTS: Of 4467 participants who underwent 9208 longitudinal cognitive sessions, 2698 (60.4%) were female, and the mean age (SD) was 74.3 (9.2) years; 3213 were cognitively unimpaired, 972 had mild cognitive impairment, and 282 had AD dementia. White matter free water (FW) showed the strongest associations with cross-sectional cognitive performance and longitudinal cognitive decline across all domains, particularly memory. FW in limbic tracts, such as the cingulum, presented the strongest associations with both memory performance (cingulum: β = -0.718; P < .001; fornix: β = -1.069; P < .001) and decline (cingulum: β = -0.115; P < .001; fornix: β = -0.153; P < .001). White matter FW measures interacted with baseline diagnosis, gray matter atrophy, APOE ε4 status, and amyloid positivity to predict poorer cognitive performance and accelerated cognitive decline. Noteworthy interactions include fornix FW and hippocampal volume (β = 10.598; P < .001), cingulum FW and SPARE-AD index (β = -0.532; P < .001), and inferior temporal gyrus transcallosal tract FW and baseline diagnosis (β = -0.537; P < .001), all predicting poorer memory performance. CONCLUSIONS AND RELEVANCE: White matter microstructural changes, particularly FW, play a critical role in cognitive decline in aging and AD-related cognitive impairment. These findings highlight the importance of FW correction in dMRI studies and highlight the limbic system, especially the cingulum and fornix, as key regions associated with cognitive decline; the interaction models highlight that integrating FW-corrected metrics with other AD biomarkers may further elucidate the biological mechanisms of neurodegeneration in aging.
引用
- Peter C, Sathe A, Shashikumar N, et al. White Matter Abnormalities and Cognition in Aging and Alzheimer Disease. JAMA Neurol. 2025. PMID: 40513084. doi:10.1001/jamaneurol.2025.1601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。